New landmark report on Telomeres and Telomerase now

available LARCHMONT, N.Y. (PROTEXT) - A special business report,Telomeres and Telomerase: Technology, Players and Opportunities,has been published by Genetic Engineering News (GEN), a divisionof Mary Ann Liebert, Inc., publishers. This is the onlycomprehensive report that covers in depth the research andproduct development based on telomeres and telomerase for bothdiagnostics and therapeutics related to their applications forcancer and anti-aging medicines. The report includes: -- Information on the 28 most important patents in telomeresand telomerase as well as coverage of the products that have beendeveloped. -- Profiles of, and complete contact information, for over 70leading pharmaceutical and biotechnology companies and academicgroups working in this field. -- A list of major researchers in the field, and informationon over 240 NIH/NSF grants. -- Interviews with the 25 leaders in the field from companiesthat include Amgen, Geron, Avi Biopharma, and PerceptiveBioSystems. -- Research developments -- Market statistics The report is available for $1295 from Mary Ann Liebert, Inc.,publishers, Two Madison Avenue, Larchmont, New York 10538. Ph:914-834-3100; e-mail: tmulak@liebertpub.com ots Original TextService: Mary Ann Liebert, Inc., publishers Internet:http://www.newsaktuell.de Contact: E. Bicovny of Mary AnnLiebert, Inc., publishers, 914-834-3100, ext. 622

Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.